Evidence brief
P21 peptide
Written and source-checked by Anthony Treviso, founder of The Peptide Field.
Direct answer
P21 peptide, also called P021 or P-21, is a short research compound made in a lab. Mouse studies reported learning and memory findings. A rat study measured changes in tau, a brain protein. These findings do not show that P21 works or is safe in people. No P021 study in people was found. No FDA-approved U.S. P21 product was found in the records checked.
P21 peptide is also called P021 or P-21. Its benefits and safety in people are not known.
- How strong is the evidence?
- Insufficient
Reliable studies in people are missing, too limited, or do not support the claim. This does not prove that the substance has no effect on the body. - What evidence exists?
- Preclinical or formulation evidence
The research used cells, animals, or product-form tests. It does not establish benefit or safety in people. - Sports rules
- Not assessed
No current sports-rule review is available.
Reviewed August 30, 2026. Sources and update notes are below.
No sales or dosing advice. This guide explains research. It was not independently medically reviewed, and it does not diagnose, prescribe, or recommend treatment.
Also known as P021 · P-21 · Peptide 021
Words used here
- peptide
- a short chain of amino acids
- preclinical
- research in cells, tissues, or animals before or outside testing in people
- formulation
- the ingredients and physical form of the finished product
- mechanism
- how a substance may cause a body change
- biomarker
- a body or lab measurement, not automatically a health benefit
- outcome
- what the study measured
- amino acid
- a small building block that makes peptides and proteins
- indication
- the approved or studied use and patient group
More detailProduct and study details
01 · Evidence profile
Four questions about the evidence
No P021 study in people was found in the searches completed on August 30, 2026.
Studies measured effects in mice, rats, or cells. They do not show what happens in people.
Animal findings cannot set a safe amount or show uncommon or long-term harms in people.
FDA identifies the chemical record. A product name alone does not show what is in the product or how it was made.
02 · Identity
What it is
P21 peptide is a short research compound made in a lab. It is also called P021 or P-21. It is based on four amino acids from a human protein that supports some nerve cells. Amino acids are small parts that can join to make peptides and proteins. Researchers added one changed amino-acid-like part. Papers count the parts in different ways. This page uses the FDA record to keep the identity clear.
Scientific group: Nerve-growth research compound. This group name describes the type of molecule or body signal. It does not prove a benefit, safety, or approval.
03 · Exact product
The molecule is not the finished product.
Formulation: The finished product's ingredients and physical form. Route: How the product enters the body. Indication: The approved or studied use and group of people for a product.
None identified in the United States.
- No FDA-approved indication
04 · Research results
What the research shows
A 2010 mouse study reported changes in learning, memory, and the growth of new brain cells. Later mouse studies reported changes in memory, nerve-cell connections, tau, or amyloid. Tau and amyloid are proteins studied in Alzheimer’s disease. An aged-rat study measured lower tau after P021 treatment. A cell study and another mouse study had mixed results. None of these studies tested P21 in people.
No P021 study in people was found. The reviewed evidence does not show whether it improves memory, prevents dementia, or treats Alzheimer’s disease in people. It also does not establish a safe amount, long-term effects, or the quality of products sold with this name. Tests in human-derived cells happen in a lab. They are not studies in people.
Exact product
FDA lists P-21, P021, and P21 under one chemical record. This record does not prove that a sold product contains the same compound used in a study. A name alone does not prove what is in a product or whether it was made safely.
05 · Claim check
Claims I checked
6 claims checked for this brief.
“In FDA’s record, P21, P021, and P-21 are names for the same chemical record.”
Yes. FDA lists P21 and P021 as names for the P-21 chemical record. This name match does not prove that a sold product has the same contents or quality.
- Evidence used
- Regulatory or product record. This answer uses an official regulator record or a specific product label.
- Limits of this answer
- The FDA chemical identity record; this does not establish drug approval, product quality, or human benefit. This answer covers only the named molecule and finished product. It also covers the product form and how people used it. The study limits include who took part, what was used for comparison, what changed, and how long the study lasted.
“P21 improved learning and memory in mouse studies.”
Yes. Studies reported learning or memory findings in normal mice and in mouse models of Alzheimer-like disease. Results in mice do not prove a benefit in people.
- Evidence used
- Preclinical evidence. This answer uses research in cells, animals, or other settings outside patient care. It does not show a benefit in people.
- Limits of this answer
- Normal adult mice and genetically changed mouse models; not people with memory problems or Alzheimer’s disease. This answer covers only the named molecule and finished product. It also covers the product form and how people used it. The study limits include who took part, what was used for comparison, what changed, and how long the study lasted.
“P21 improves memory or treats Alzheimer’s disease in people.”
The reviewed studies used mice, rats, or cells. The P021 registry search found no study in people. Animal or cell findings cannot show that P21 treats people.
- Evidence used
- No reliable human outcome evidence. No reliable study in people shows the health outcome in this statement.
- Limits of this answer
- Memory or Alzheimer’s disease outcomes in people who received a verified P21 study product. This answer covers only the named molecule and finished product. It also covers the product form and how people used it. The study limits include who took part, what was used for comparison, what changed, and how long the study lasted.
Show 3 more claim checks
“A P21 substance record means P21 is FDA-approved.”
FDA says a Unique Ingredient Identifier, or UNII, helps identify a substance. It does not mean that FDA reviewed or approved a drug. No FDA-approved P21 product was found under the reviewed names.
- Evidence used
- Regulatory or product record. This answer uses an official regulator record or a specific product label.
- Limits of this answer
- United States drug-approval status as checked for P21, P021, and P-21 on August 30, 2026. This answer covers only the named molecule and finished product. It also covers the product form and how people used it. The study limits include who took part, what was used for comparison, what changed, and how long the study lasted.
“P21 peptide is the same thing as the p21/CDKN1A protein.”
No. P21 peptide is a small compound made in a lab. CDKN1A is a human gene. It makes a protein also called p21. The shared short name does not make them the same.
- Evidence used
- Regulatory or product record. This answer uses an official regulator record or a specific product label.
- Limits of this answer
- P21 peptide identity compared with the human CDKN1A gene and p21 protein. This answer covers only the named molecule and finished product. It also covers the product form and how people used it. The study limits include who took part, what was used for comparison, what changed, and how long the study lasted.
“P21 has a proven safety profile in people.”
The P021 registry search found no study in people. Animal studies cannot set a safe amount, rule out uncommon harm, or show long-term safety for people.
- Evidence used
- No reliable human outcome evidence. No reliable study in people shows the health outcome in this statement.
- Limits of this answer
- People exposed to a verified P21 study product, with enough follow-up to assess harms. This answer covers only the named molecule and finished product. It also covers the product form and how people used it. The study limits include who took part, what was used for comparison, what changed, and how long the study lasted.
06 · Questions
Questions people ask about P21 peptide
No. P21 peptide is a small lab-made research compound. CDKN1A is a human gene that makes a protein also called p21. The shared short name does not make them the same.
No FDA-approved U.S. P21 product was found in the records checked. FDA’s chemical record identifies the substance. It does not approve a drug.
Not assessed. This editorial review did not determine sport eligibility. Athletes must check the current prohibited list, Global DRO, and their governing body. This status is not personal clearance to compete.
A 2010 mouse study reported changes in learning, memory, and the growth of new brain cells. Later mouse studies reported changes in memory, nerve-cell connections, tau, or amyloid. Tau and amyloid are proteins studied in Alzheimer’s disease. An aged-rat study measured lower tau after P021 treatment. A cell study and another mouse study had mixed results. None of these studies tested P21 in people.
No P021 study in people was found. The reviewed evidence does not show whether it improves memory, prevents dementia, or treats Alzheimer’s disease in people. It also does not establish a safe amount, long-term effects, or the quality of products sold with this name. Tests in human-derived cells happen in a lab. They are not studies in people.
07 · Safety
Safety limits for this record
No reviewed study sets a safe amount or way to take P21. Long-term safety in people is also unknown. This guide gives no directions for use, buying advice, or treatment advice.
This editorial review did not determine sport eligibility. Athletes must check the current prohibited list, Global DRO, and their governing body.
No current sports-rule review is available.
Reviewed .Check current rules for tested sport ↗08 · Sources
Read the sources
09 · Review history
Review history
Initial brief reviewed the FDA chemical record, primary animal and cell studies, the p21/CDKN1A name conflict, a ClinicalTrials.gov search for P021, and FDA drug-approval databases.
Written and source-checked by Anthony Treviso, founder of The Peptide Field.
Not independently medically reviewed. This page is not a dosing, sourcing, or treatment guide.